Literature DB >> 3079956

Enhancement of endotoxin-induced isolated renal tubular cell injury by toxic shock syndrome toxin 1.

W F Keane, G Gekker, P M Schlievert, P K Peterson.   

Abstract

The pathogenesis of toxic shock syndrome (TSS) remains unknown. On the basis of experimental data, it has been hypothesized that staphylococcal TSS Toxin 1 (TSST-1) may interact synergistically with low levels of endotoxin and give rise to many of the clinical findings. We have demonstrated previously that lipid A, the biologically active component of lipopolysaccharide (LPS), or endotoxin, induces dose-dependent necrosis of isolated rat renal tubular cells (RTCs). In the present studies, the authors investigated whether this injury could be augmented by TSST-1. The viability of RTCs was assessed by vital dye exclusion. Incubation of freshly isolated rat RTCs with either 1 ng/ml of TSST-1 or 0.1 ng/ml LPS or lipid A had minimal cytotoxicity (less than 6%). Exposure of RTCs to 1 ng/ml TSST-1 for 20 minutes, followed by washing, resulted in a significant enhancement of cytotoxicity when RTCs were exposed to 0.1 ng/ml LPS or lipid A. The sensitization of RTCs by TSST-1 to LPS- or lipid-A-induced injury was prevented by methylamine and chloroquine, two inhibitors of receptor-mediated endocytosis (RME). Chelation of extracellular calcium by 2 mM EGTA also blocked the TSST-1-induced sensitization of RTCs to LPS or lipid A. Inhibition of RTC arachidonic acid metabolism by methylprednisolone, indomethacin, ibuprofen, and piriprost significantly inhibited RTC necrosis induced by TSST-1 and LPS or lipid A by 33-62%. Thiourea and deferoxamine, agents which ameliorate oxidant injury, also inhibited this synergistic injury by 34-67%. Thus, TSST-1 enhanced the cytotoxic effects of LPS/lipid A, and the sensitization of RTCs appeared to involve RME or TSST-1. Oxidative metabolism of arachidonic acid and generation of reactive oxygen species appeared to participate in LPS/lipid-A-mediated RTC death.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3079956      PMCID: PMC1888123     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  27 in total

Review 1.  Possible host-defense mechanisms in toxic shock syndrome.

Authors:  J P Davis; J M Vergeront; P J Chesney
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

2.  Staphylococcal toxic shock toxin specifically binds to cultured human epithelial cells and is rapidly internalized.

Authors:  V M Kushnaryov; H S MacDonald; R Reiser; M S Bergdoll
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

3.  Protection against staphylococcal pyrogenic exotoxin type C-enhanced endotoxin lethality with methylprednisolone and IgG.

Authors:  P K Peterson; P M Schlievert; W Conroy; J A Kelly; J Spika; P G Quie
Journal:  J Infect Dis       Date:  1983-02       Impact factor: 5.226

4.  Iron-catalyzed hydroxyl radical formation. Stringent requirement for free iron coordination site.

Authors:  E Graf; J R Mahoney; R G Bryant; J W Eaton
Journal:  J Biol Chem       Date:  1984-03-25       Impact factor: 5.157

5.  An enterotoxin-like protein in Staphylococcus aureus strains from patients with toxic shock syndrome.

Authors:  M S Bergdoll; B A Crass; R F Reiser; R N Robbins; A C Lee; P J Chesney; J P Davis; J M Vergeront; P J Wand
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

6.  Toxic shock syndrome: clinical, laboratory, and pathologic findings in nine fatal cases.

Authors:  S M Larkin; D N Williams; M T Osterholm; R W Tofte; Z Posalaky
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

7.  Prevalence of serum antibody to staphylococcal enterotoxin F among Wisconsin residents: implications for toxic-shock syndrome.

Authors:  J M Vergeront; S J Stolz; B A Crass; D B Nelson; J P Davis; M S Bergdoll
Journal:  J Infect Dis       Date:  1983-10       Impact factor: 5.226

8.  Induction of human interleukin-1 by a product of Staphylococcus aureus associated with toxic shock syndrome.

Authors:  T Ikejima; C A Dinarello; D M Gill; S M Wolff
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

9.  Initial events during phagocytosis by macrophages viewed from outside and inside the cell: membrane-particle interactions and clathrin.

Authors:  J Aggeler; Z Werb
Journal:  J Cell Biol       Date:  1982-09       Impact factor: 10.539

10.  Presence of an extensive clathrin coat on the apical plasmalemma of the rat kidney proximal tubule cell.

Authors:  J S Rodman; D Kerjaschki; E Merisko; M G Farquhar
Journal:  J Cell Biol       Date:  1984-05       Impact factor: 10.539

View more
  12 in total

Review 1.  Exotoxins of Staphylococcus aureus.

Authors:  M M Dinges; P M Orwin; P M Schlievert
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

2.  Immune cell lethality induced by streptococcal pyrogenic exotoxin A and endotoxin.

Authors:  B A Leonard; P M Schlievert
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

3.  Identification of RTX toxin target cell specificity domains by use of hybrid genes.

Authors:  C Forestier; R A Welch
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

4.  Pro-inflammatory and oxidative effects of noncrystalline uric acid in human mesangial cells: contribution to hyperuricemic glomerular damage.

Authors:  M S Convento; E Pessoa; M A Dalboni; F T Borges; N Schor
Journal:  Urol Res       Date:  2010-06-04

5.  Synergistic induction of interleukin-1 by endotoxin and toxic shock syndrome toxin-1 using rat macrophages.

Authors:  D H Beezhold; G K Best; P F Bonventre; M Thompson
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

6.  Mechanism of Escherichia coli alpha-hemolysin-induced injury to isolated renal tubular cells.

Authors:  W F Keane; R Welch; G Gekker; P K Peterson
Journal:  Am J Pathol       Date:  1987-02       Impact factor: 4.307

7.  Correlation of temperature and toxicity in murine studies of staphylococcal enterotoxins and toxic shock syndrome toxin 1.

Authors:  B G Stiles; Y G Campbell; R M Castle; S A Grove
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

Review 8.  Tissue-engineered kidney disease models.

Authors:  Teresa M Desrochers; Erica Palma; David L Kaplan
Journal:  Adv Drug Deliv Rev       Date:  2013-12-17       Impact factor: 15.470

9.  Biological activity of toxic shock syndrome toxin 1 and a site-directed mutant, H135A, in a lipopolysaccharide-potentiated mouse lethality model.

Authors:  B G Stiles; T Krakauer; P F Bonventre
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

10.  Possibility of separating toxins from bacteria associated with sudden infant death syndrome using anion exchange chromatography.

Authors:  D B Drucker; H A Aluyi; J A Morris; D R Telford; B A Oppenheim; B A Crawley
Journal:  J Clin Pathol       Date:  1992-09       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.